| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |